de Alencar Rodrigo Gomes, de Oliveira Aline Carlos, Lima Eliana Martins, da Cunha-Filho Marcílio Sérgio Soares, Taveira Stephânia Fleury, Marreto Ricardo Neves
Laboratory of Pharmaceutical Tecnology, School of Pharmacy, Universidade Federal de Goiás (UFG), Rua 240, Setor Leste Universitário, 74 605-170, Goiânia, GO, Brazil.
Laboratory of Food, Drug and Cosmetics (LTMAC), Universidade de Brasilia (UnB), Campus Universitário Darcy Ribeiro, Asa Norte, 70 910-900, Brasília, DF, Brazil.
AAPS PharmSciTech. 2017 Aug;18(6):2260-2268. doi: 10.1208/s12249-016-0700-2. Epub 2017 Jan 10.
Pellet-containing tablets for colon-specific drug delivery present higher targeting efficiency and lower costs when compared with monolithic tablets and pellet-filled capsules, respectively. In this study, pellets containing ketoprofen were coated with different acrylic polymers and submitted to compaction. The influence of formulation and process factors on film integrity was then evaluated. Pellets were prepared via extrusion-spheronization and coated using two acrylic polymers (Eudragit® FS 30 D and Opadry® 94 k28327, PMMA and PMA, respectively). The resulting pellets were mixed with placebo granules and compressed in a hydraulic press. Multiple regression showed that ketoprofen release from pellet-containing tablets is predominantly influenced by pellet content, hardness, friability, and disintegration time. PMA-containing tablets prepared under low compaction force or with low pellet content showed rapid disintegration (<1 min) and ketoprofen release similar to those of uncompressed coated pellets (∼30% at 360 min of experiment). On the other hand, PMMA-containing tablets showed a higher rupture level, and those prepared with higher pellet content gave rise to a non-disintegrating matrix. Coated pellets were shown to be able to target ketoprofen to the colonic region. Targeting capacity was dependent on the physicochemical characteristics of the tablets.
与整体片剂和含微丸胶囊相比,用于结肠特异性药物递送的含微丸片剂分别具有更高的靶向效率和更低的成本。在本研究中,将含酮洛芬的微丸用不同的丙烯酸聚合物包衣并进行压片。然后评估制剂和工艺因素对薄膜完整性的影响。微丸通过挤出滚圆法制备,并使用两种丙烯酸聚合物(分别为Eudragit® FS 30 D和Opadry® 94 k28327,即聚甲基丙烯酸甲酯和聚甲基丙烯酸)进行包衣。将所得微丸与安慰剂颗粒混合,并在液压机中压片。多元回归分析表明,含微丸片剂中酮洛芬的释放主要受微丸含量、硬度、脆碎度和崩解时间的影响。在低压力或低微丸含量下制备的含聚甲基丙烯酸的片剂显示出快速崩解(<1分钟),且酮洛芬的释放与未压片的包衣微丸相似(实验360分钟时约为30%)。另一方面,含聚甲基丙烯酸甲酯的片剂显示出更高的破裂水平,且那些高微丸含量制备的片剂形成了不崩解的基质。结果表明,包衣微丸能够将酮洛芬靶向递送至结肠区域。靶向能力取决于片剂的物理化学特性。